Reported Standalone quarterly numbers for Mangalam Drugs & Organics are:
Net Sales at Rs 57.35 crore in June 2025 down 25.07% from Rs. 76.54 crore in June 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 13.73 crore in June 2025 down 611.34% from Rs. 2.68 crore in June 2024.
EBITDA stands negative at Rs. 4.50 crore in June 2025 down 154.88% from Rs. 8.20 crore in June 2024.
Mangalam Drugs shares closed at 79.74 on August 20, 2025 (NSE) and has given -22.16% returns over the last 6 months and -36.21% over the last 12 months.
Story continues below Advertisement
| Mangalam Drugs & Organics | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'25 | Mar'25 | Jun'24 | | Net Sales/Income from operations | 57.21 | 72.78 | 76.49 | | Other Operating Income | 0.14 | 0.26 | 0.04 | | Total Income From Operations | 57.35 | 73.04 | 76.54 | | EXPENDITURE | | Consumption of Raw Materials | 23.33 | 41.76 | 40.53 | | Purchase of Traded Goods | -- | 6.19 | 6.07 | | Increase/Decrease in Stocks | 16.25 | -12.59 | -6.20 | | Power & Fuel | -- | -- | -- | | Employees Cost | 9.31 | 10.50 | 9.57 | | Depreciation | 4.38 | 4.61 | 3.87 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 12.96 | 17.02 | 18.37 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -8.88 | 5.55 | 4.31 | | Other Income | 0.00 | 0.21 | 0.02 | | P/L Before Int., Excpt. Items & Tax | -8.88 | 5.76 | 4.33 | | Interest | 4.04 | 4.03 | 3.75 | | P/L Before Exceptional Items & Tax | -12.93 | 1.73 | 0.58 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -12.93 | 1.73 | 0.58 | | Tax | 0.80 | 1.58 | -2.10 | | P/L After Tax from Ordinary Activities | -13.73 | 0.15 | 2.68 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -13.73 | 0.15 | 2.68 | | Equity Share Capital | 15.83 | 15.83 | 15.83 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -8.67 | 0.10 | 1.70 | | Diluted EPS | -8.67 | 0.10 | 1.70 | | EPS After Extra Ordinary | | Basic EPS | -8.67 | 0.10 | 1.70 | | Diluted EPS | -8.67 | 0.10 | 1.70 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
